{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:00:27Z","timestamp":1761490827922,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.transci.2019.06.007","type":"journal-article","created":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T10:31:49Z","timestamp":1561199509000},"page":"532-537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Reflections on current status of blood transfusion transplant viral safety in UK\/Europe and on novel strategies for enhancing donors\/recipients healthcare in promising era of advanced cell therapy\/regenerative medicine"],"prefix":"10.1016","volume":"58","author":[{"given":"Jerard","family":"Seghatchian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.transci.2019.06.007_bib0005","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/vr.145.16.460","article-title":"Potential contamination of beef carcasses with brain tissue at slaughter","volume":"145","author":"Anil","year":"1999","journal-title":"Vet Rec"},{"key":"10.1016\/j.transci.2019.06.007_bib0010","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.transci.2016.10.016","article-title":"Hepatitis E Virus: emerging from the shadows in developed countries","volume":"55","author":"Dalton","year":"2016","journal-title":"Tranfus Aphesis Sci"},{"key":"10.1016\/j.transci.2019.06.007_bib0015","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.transci.2017.05.023","article-title":"The microbiome and transfusion in cancer patients","volume":"56","author":"Goubran","year":"2017","journal-title":"Tranfus Aphesis Sci"},{"key":"10.1016\/j.transci.2019.06.007_bib0020","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.transci.2018.09.004","article-title":"Reflections on the dynamics of bacterial and viral contamination of blood components and the levels of efficacy for pathogen inactivation processes","volume":"57","author":"Bah","year":"2018","journal-title":"Tranfus Aphesis Sci"},{"issue":"9956","key":"10.1016\/j.transci.2019.06.007_bib0025","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/S0140-6736(14)61034-5","article-title":"Hepatitis E virus in blood components: a prevalence and transmission study in southeast England","volume":"384","author":"Hewitt","year":"2014","journal-title":"Lancet"},{"year":"2016","series-title":"Hepatitis E: symptoms, transmission, treatment and prevention","author":"Public Health England","key":"10.1016\/j.transci.2019.06.007_bib0030"},{"key":"10.1016\/j.transci.2019.06.007_bib0035","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.16.30514","article-title":"Hepatitis E and blood donation safety in selected European countries: a shift to screening?","volume":"22","author":"Domanovic","year":"2017","journal-title":"Euro Surveill"},{"key":"10.1016\/j.transci.2019.06.007_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2019.03.011","article-title":"New monoclonal\/bi -specific antibodies: reshaping transfusion medicine beyond replacement","author":"Goubran","year":"2019","journal-title":"Tranfus Aphesis Sci"},{"key":"10.1016\/j.transci.2019.06.007_bib0045","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.transci.2016.10.019","article-title":"Insight into red blood cell storage lesion: toward a new appreciation","volume":"55","author":"Antonelou","year":"2016","journal-title":"Tranfus Aphesis Sci"},{"key":"10.1016\/j.transci.2019.06.007_bib0050","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.transci.2018.12.015","article-title":"Ex vivo generation of transfusable red cells blood units from various stem cell sources: a concise revisit of where we are now","volume":"58","author":"Christaki","year":"2019","journal-title":"Tranfus Aphesis Sci"},{"key":"10.1016\/j.transci.2019.06.007_bib0055","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/trf.14435","article-title":"Proceedings of the Food and Drug Administration\u2019s public workshop on new red blood cell product regulatory science 2016","volume":"58","author":"Vostal","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2019.06.007_sbref0060a","first-page":"245","article-title":"From omics technologies to personalized transfusion medicine. Expert Rev Proteomics 2019; 16: 215-225; Seghatchian J. Evolving concepts of the RBC storage lesion using Omics and other novel diagnostic tools","volume":"56","author":"D\u2019Alessandro","year":"2017","journal-title":"Tranfus Aphesis Sci"},{"key":"10.1016\/j.transci.2019.06.007_sbref0060b","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.transci.2017.03.006","article-title":"Hitcher\u2019s guide to red cell storage galaxy: omics technologies and the quality issue","volume":"56","author":"D\u2019Alessandro","year":"2017","journal-title":"Tranfus Aphesis Sci"},{"key":"10.1016\/j.transci.2019.06.007_bib0065","first-page":"348","article-title":"Cumulative erythrocyte damage in blood storage and relevance to massive transfusions: selective insights into serial morphological and biochemical findings","volume":"15","author":"Putter","year":"2017","journal-title":"Blood Transfus"},{"key":"10.1016\/j.transci.2019.06.007_bib0070","first-page":"625","article-title":"Erythrocyte- based drug delivery in transfusion medicine: wandering questions seeking answers","volume":"56","author":"Tzounakas","year":"2017","journal-title":"Tranfus Aphesis Sci"},{"key":"10.1016\/j.transci.2019.06.007_bib0075","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.transci.2017.03.007","article-title":"Extracellular vesicle characteristics in stored red cell concentrates are influenced by the method of detection","volume":"56","author":"Almizraq","year":"2017","journal-title":"Tranfus Aphesis Sci"},{"key":"10.1016\/j.transci.2019.06.007_bib0080","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.transci.2016.04.013","article-title":"Smart blood cell and microvesicles-based Trojan horse drug delivery","volume":"54","author":"Wu","year":"2016","journal-title":"Tranfus Aphesis Sci"},{"issue":"3","key":"10.1016\/j.transci.2019.06.007_bib0085","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.transci.2016.10.017","article-title":"Drug delivery by erythrocytes: \u201cprimum non nocere\u201d","volume":"55","author":"Villa","year":"2016","journal-title":"Tranfus Aphesis Sci"},{"issue":"2","key":"10.1016\/j.transci.2019.06.007_bib0090","first-page":"126","article-title":"Unraveling the Gordian Knot of red cell storage lesion and its clinical relevance","volume":"15","author":"Tzounakas","year":"2017","journal-title":"Blood Transfusion"},{"key":"10.1016\/j.transci.2019.06.007_bib0095","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.transci.2018.05.018","article-title":"Red cell transfusion in paediatric patients with thalassaemia and sickle cell disease: current status, challenges and perspectives","volume":"57","author":"Tzounakas","year":"2018","journal-title":"Tranfus Aphesis Sci"},{"key":"10.1016\/j.transci.2019.06.007_sbref0100a","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.transci.2018.05.022","article-title":"Special considerations for the use of pathogen reduced blood components in pediatric patients: an overview","volume":"57","author":"Goodrich","year":"2018","journal-title":"Tranfus Aphesis Sci"},{"issue":"15","key":"10.1016\/j.transci.2019.06.007_sbref0100b","first-page":"512","article-title":"Toward pathogen inactivation of red and whole blood targeting viral DNA\/RNA: design technologies and future prospects for developing countries","author":"Drew","year":"2017","journal-title":"Blood Transfusion"},{"key":"10.1016\/j.transci.2019.06.007_bib0105","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.transci.2017.08.021","article-title":"Comparison of three platelet lysates used as supplement for in vitro- expansion of corneal endothelium cells","volume":"56","author":"Wang","year":"2017","journal-title":"Tranfus Aphesis Sci"},{"key":"10.1016\/j.transci.2019.06.007_bib0110","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.transci.2015.10.007","article-title":"Blood cell-derived microvesicles with potential pathogenic roles in therapeutic blood components and specialized diagnostic tools in diseases","volume":"53","author":"Seghatchian","year":"2015","journal-title":"Tranfus Aphesis Sci"},{"key":"10.1016\/j.transci.2019.06.007_sbref0115a","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.transci.2015.05.013","volume":"53","author":"Seghatchian","year":"2015","journal-title":"Tranfus Aphesis Sci"},{"key":"10.1016\/j.transci.2019.06.007_sbref0115b","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.transci.2016.01.024","article-title":"Commentary on technical specifications and safety requirements of serum eye drops: keeping a close eye on the content in cytokines","volume":"54","author":"Seghatchian","year":"2016","journal-title":"Tranfus Aphesis Sci"},{"key":"10.1016\/j.transci.2019.06.007_sbref0115c","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.transci.2016.01.022","article-title":"Quality, safety and efficacy of blood-derived serum eye drops: an overview","volume":"54","author":"Van der Meer","year":"2016","journal-title":"Tranfus Aphesis Sci"},{"key":"10.1016\/j.transci.2019.06.007_bib0120","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2019.1593755","article-title":"Clinical requirements for extracellular vesicle assays","volume":"8","author":"Ayers","year":"2019","journal-title":"J Extracellular Vesicles"},{"issue":"February 23","key":"10.1016\/j.transci.2019.06.007_bib0125","article-title":"Reflections on dry eye syndrome treatment: therapeutic role of blood products","author":"Drew","year":"2018","journal-title":"Front Med"},{"key":"10.1016\/j.transci.2019.06.007_bib0130","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.transci.2018.05.004","article-title":"Artificial Inteligence: a joint narrative on potential use in pediatric stem and immune cell therapies and regenerative medicine","volume":"57","author":"Sniecinski","year":"2018","journal-title":"Tranfus Aphesis Sci"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050219300990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050219300990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:49:58Z","timestamp":1761468598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050219300990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1473050219300990"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2019.06.007","relation":{},"ISSN":["1473-0502"],"issn-type":[{"type":"print","value":"1473-0502"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reflections on current status of blood transfusion transplant viral safety in UK\/Europe and on novel strategies for enhancing donors\/recipients healthcare in promising era of advanced cell therapy\/regenerative medicine","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2019.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}